ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering | Markets Insider

SAN MATEO, Calif. and SINGAPORE, March 12, 2024 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals Ltd. (Nasdaq: ASLN), a clinical-stage, immunology focu.

Do you trust this headline?

Based on recent headline ratings, 100% of this readership currently trusts the local media, which has an average score of 83% regionally and is currently trending positivepositive.

100%

Media Trust Score100%

In